Atlas Trials

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

Clinical trial NCT02497898 · NOT_YET_RECRUITING

Trial details

NCT number
NCT02497898
Sponsor
The First People's Hospital of Changzhou
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma, Non-Hodgkin
Start date
2015-07-01
Primary completion
2038-07-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.